TRIFLUOPERAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trifluoperazine Hydrochloride, and what generic alternatives are available?
Trifluoperazine Hydrochloride is a drug marketed by Fosun Pharma, Wockhardt, Athem, Duramed Pharms Barr, Ivax Pharms, Mylan, Sandoz, and Watson Labs. and is included in twenty NDAs.
The generic ingredient in TRIFLUOPERAZINE HYDROCHLORIDE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluoperazine Hydrochloride
A generic version of TRIFLUOPERAZINE HYDROCHLORIDE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIFLUOPERAZINE HYDROCHLORIDE?
- What are the global sales for TRIFLUOPERAZINE HYDROCHLORIDE?
- What is Average Wholesale Price for TRIFLUOPERAZINE HYDROCHLORIDE?
Summary for TRIFLUOPERAZINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 20 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 151 |
Clinical Trials: | 7 |
Patent Applications: | 172 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRIFLUOPERAZINE HYDROCHLORIDE at DailyMed |
![TRIFLUOPERAZINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for TRIFLUOPERAZINE HYDROCHLORIDE](/p/graph/s/t/TRIFLUOPERAZINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for TRIFLUOPERAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Adrianna Vlachos | Phase 1/Phase 2 |
Lindner Center of HOPE | Phase 2 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Pharmacology for TRIFLUOPERAZINE HYDROCHLORIDE
Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for TRIFLUOPERAZINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRIFLUOPERAZINE HYDROCHLORIDE
US Patents and Regulatory Information for TRIFLUOPERAZINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fosun Pharma | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | CONCENTRATE;ORAL | 085787-001 | Apr 15, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | TABLET;ORAL | 040209-004 | Jul 7, 1997 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | TABLET;ORAL | 085976-001 | Jun 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |